YLYuhao Li

Yuhao Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuhao Li has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    55-Week Treatment of Mice with theUnaniandAyurvedicMedicine Pomegranate Flower Ameliorates Ageing-Associated Insulin Resistance and Skin Abnormalities

    by Jianwei Wang, Xianglu Rong, Irene S. I. Um, Johji Yamahara, Yuhao Li

    PPARs play a pivotal role in regulating lipid and glucose homeostasis and are involved in diverse biological activities in skin. Pomegranate flower (PGF, an antidiabetic therapy inUnaniandAyurvedicmedicines) has been previously demonstrated to activate both PPARalpha/gamma. Here, we found that treatment of mice with the diet containing PGF powder over 55 weeks attenuated ageing-induced abnormal increases in the homeostasis model assessment of insulin resistance, glucose concentrations during oral glucose tolerance test, and adipose insulin resistance index. The diet tended to decrease the excessive peri-ovary fat mass. It, however, increased the thinned subcutaneous fat thickness. In addition, the diet restored decreases in skin water content, epidermis thickness, and collagen density in corium. Thus, our results demonstrate that long-term treatment with theUnaniandAyurvedictherapy ameliorates ageing-induced insulin resistance, which is associated with reversal of ageing-induced fat redistribution. Further, PGF attenuates ageing-mediated undesirable skin abnormalities.


  • Open Access

    The Ayurvedic Medicine Salacia oblonga Attenuates Diabetic Renal Fibrosis in Rats: Suppression of Angiotensin II/AT1 Signaling

    by Lan He, Yanfei Qi, Xianglu Rong, Jianmin Jiang, Qinglin Yang, Johji Yamahara, Michael Murray, Yuhao Li

    In human diabetic nephropathy, the extent of tubulointerstitial fibrosis is the leading cause of end‐stage renal disease; fibrosis is closely correlated with renal dysfunction. Although a wide array of medicinal plants play a role in the prevention and treatment of diabetes, there are few reports of the application of herbal medicines in amelioration of renal fibrosis, or the underlying mechanisms by which such benefits are mediated. The efficacy of the Ayurvedic antidiabetic medicine Salacia oblonga (SO) root on rat renal fibrosis was investigated. An aqueous extract from SO (100 mg/kg, p.o., 6 weeks) diminished renal glomerulosclerosis and interstitial fibrosis in Zucker diabetic fatty (ZDF) rats, as revealed by van Giesen‐staining. SO also reduced renal salt‐soluble, acid‐soluble and salt‐insoluble collagen contents. These changes were accompanied by normalization of hypoalbuminemia and BUN. Gene profiling revealed that the increase in transcripts encoding the glomerulosclerotic mediators collagen I, collagen IV, fibronectin, angiotensin II type 1 receptor (AT1), transforming growth factor (TGF)‐β1, plasminogen activator inhibitor (PAI)‐1 observed in ZDF rat kidney was suppressed by SO. In rat‐derived mesangial cells, similar to the effect of the AT1 antagonist telmisartan, SO and its major component mangiferin suppressed the stimulatory effect of angiotensin II on proliferation and increased mRNA expression and/or activities of collagen I, collagen IV, fibronectin, AT1, TGF‐β1 and PAI‐1. Considered together the present findings demonstrate that SO attenuates diabetic renal fibrosis, at least in part by suppressing anigiotensin II/AT1 signaling. Further, it now emerges that mangiferin is an effective antifibrogenic agent.


  • A 35-day gavage safety assessment of ginger in rats

    by Xianglu Rong, Gang Peng, Takuya Suzuki, Qinglin Yang, Johji Yamahara, Yuhao Li


  • Increased renal collagen cross‐linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats

    by Yuhao Li, Yanfei Qi, Moon Sun Kim, Kevin Zhe‐Yang Xu, Tom Hsun‐Wei Huang, Xianglu Rong, Michael Murray, Johji Yamahara

    Background: Zucker diabetic fatty (ZDF) rat is a genetic model of type 2 diabetes and obesity. The mechanism underlying nephropathy in ZDF rats, however, remains unclear.Methods: ZDF rats were compared to age‐matched Zucker lean (ZL) rats. Physiological and blood biochemical parameters, renal glomerular cross‐sectional area (hematoxylin‐eosin staining), fibrosis (van Giesen staining), collagen composition (Sircol Collagen Assay), lipids (enzymatic method) and mRNA expression (RT‐PCR) were determined.Results: ZDF rats showed an increase in renal‐insoluble collagen content and the ratio of renal‐insoluble to salt‐soluble collagen (2‐ and 1.5‐fold of the control animals). There were increases in renal glomerulosclerosis and interstitial fibrosis in ZDF rats (increased to 2‐fold) in the glomerular mesangium and tubulointerstitium, and increased glomerular area. Renal triglyceride accumulated to greater than 2‐fold of those levels in ZL rats. These changes were accompanied by hypoalbuminemia, and elevated plasma blood urea nitrogen and uric acid levels. Gene profiling showed increased expression of transcripts encoding the glomerulosclerotic mediator collagens I and IV, plasminogen activator inhibitor‐1, transforming growth factor‐β1, and angiotensin II type 1 receptor in ZDF rat kidney. Moreover, renal expression of mRNAs encoding sterol regulatory element‐binding protein‐1, a nuclear transcription factor that activates genes involved in fatty acid synthesis, and acetyl‐CoA carboxylase, a key enzyme that mediates fatty acid synthesis, was increased in ZDF rats.Conclusions: Our findings suggest that dysregulated gene expression may result in increased renal collagen cross‐linking and lipid accumulation, that may be associated with development of nephropathy in the animal model of type 2 diabetes and obesity. Copyright © 2008 John Wiley & Sons, Ltd.


  • Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor

    by T. H. Huang, L. He, Q. Qin, Q. Yang, G. Peng, M. Harada, Y. Qi, J. Yamahara, B. D. Roufogalis, Y. Li

    Aims:  We investigated the effect of the water extract of Salacia oblonga (SOE), an ayurvedic antidiabetic and antiobesity medicine, on obesity and diabetes‐associated cardiac hypertrophy and discuss the role of modulation of cardiac angiotensin II type 1 receptor (AT 1 ) expression in the effect. Methods:  SOE (100 mg/kg) was given orally to male Zucker diabetic fatty (ZDF) rats for 7 weeks. At the end‐point of the treatment, the hearts and left ventricles were weighed, cardiomyocyte cross‐sectional areas were measured, and cardiac gene profiles were analysed. On the other hand, angiotensin II–stimulated embryonic rat heart–derived H9c2 cells and neonatal rat cardiac fibroblasts were pretreated with SOE and one of its prominent components mangiferin (MA), respectively. Atrial natriuretic peptide (ANP) mRNA expression and protein synthesis and [ 3 H]thymidine incorporation were determined. Results:  SOE‐treated ZDF rats showed less cardiac hypertrophy (decrease in weights of the hearts and left ventricles and reduced cardiomyocyte cross‐sectional areas). SOE treatment suppressed cardiac overexpression of ANP, brain natriuretic peptide (BNP) and AT 1 mRNAs and AT 1 protein in ZDF rats. SOE (50–100 μg/ml) and MA (25 μmol) suppressed angiotensin II–induced ANP mRNA overexpression and protein synthesis in H9c2 cells. They also inhibited angiotensin II–stimulated [ 3 H]thymidine incorporation by cardiac fibroblasts. Conclusions:  Our findings demonstrate that SOE decreases cardiac hypertrophy in ZDF rats, at least in part by inhibiting cardiac AT 1 overexpression. These studies provide insights into a potential cardioprotective role of a traditional herb, which supports further clinical evaluation in obesity and diabetes‐associated cardiac hypertrophy.


  • Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR‐α/‐γ activator properties

    by Yuhao Li, Yanfei Qi, Tom H. W. Huang, Johji Yamahara, Basil D. Roufogalis

    PPARs are transcription factors belonging to the superfamily of nuclear receptors. PPAR‐α is involved in the regulation of fatty acid (FA) uptake and oxidation, inflammation and vascular function, while PPAR‐γ participates in FA uptake and storage, glucose homeostasis and inflammation. The PPARs are thus major regulators of lipid and glucose metabolism. Synthetic PPAR‐α or PPAR‐γ agonists have been widely used in the treatment of dyslipidaemia, hyperglycaemia and their complications. However, they are associated with an incidence of adverse events. Given the favourable metabolic effects of both PPAR‐α and PPAR‐γ activators, as well as their potential to modulate vascular disease, combined PPAR‐α/‐γ activation has recently emerged as a promising concept, leading to the development of mixed PPAR‐α/‐γ activators. However, some major side effects associated with the synthetic dual activators have been reported. It is unclear whether this is a specific effect of the particular synthetic compounds or a class effect. To date, a medication that may combine the beneficial metabolic effects of PPAR‐α and PPAR‐γ activation with fewer undesirable side effects has not been successfully developed. Pomegranate plant parts are used traditionally for the treatment of various disorders. However, only pomegranate flower has been prescribed in Unani and Ayurvedic medicines for the treatment of diabetes. This review provides a new understanding of the dual PPAR‐α/‐γ activator properties of pomegranate flower in the potential treatment of diabetes and its associated complications.


  • Pomegranate Flower Extract Diminishes Cardiac Fibrosis in Zucker Diabetic Fatty Rats

    by Tom H. W B Pharm (Hons ) Huang, Qinglin Yang, Masaki Harada, George Q Li, Johji Yamahara, Basil D PhD Roufogalis, Yuhao Li

    The diabetic heart shows increased fibrosis, which impairs cardiac function. Endothelin (ET)-1 and nuclear factor-kappaB (NF-κB) interactively regulate fibroblast growth. We have recently demonstrated that Punica granatum flower (PGF), a Unani anti-diabetic medicine, is a dual activator of peroxisome proliferator-activated receptor (PPAR)-α and -γ, and improves hyperglycemia, hyperlipidemia, and fatty heart in Zucker diabetic fatty (ZDF) rat, a genetic animal model of type 2 diabetes and obesity. Here, we demonstrated that six-week treatment with PGF extract (500 mg/kg, p.o.) in Zucker diabetic fatty rats reduced the ratios of van Gieson-stained interstitial collagen deposit area to total left ventricular area and perivascular collagen deposit areas to coronary artery media area in the heart. This was accompanied by suppression of overexpressed cardiac fibronectin and collagen I and III mRNAs. Punica granatum flower extract reduced the up-regulated cardiac mRNA expression of ET-1, ETA, inhibitor-κBβ and c-jun, and normalized the down-regulated mRNA expression of inhibitor-κBα in Zucker diabetic fatty rats. In vitro, Punica granatum flower extract and its components oleanolic acid, ursolic acid, and gallic acid inhibited lipopolysaccharide-induced NF-κB activation in macrophages. Our findings indicate that Punica granatum flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats, at least in part, by modulating cardiac ET-1 and NF-κB signaling.


  • Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids

    by Tom Hsun‐Wei Huang, Gang Peng, Bhavani Prasad Kota, George Qian Li, Johji Yamahara, Basil D Roufogalis, Yuhao Li

    Excess triglyceride (TG) accumulation and increased fatty acid (FA) oxidation in the diabetic heart contribute to cardiac dysfunction. Punica granatum flower (PGF) is a traditional antidiabetic medicine. Here, we investigated the effects and mechanisms of action of PGF extract on abnormal cardiac lipid metabolism both in vivo and in vitro. Long‐term oral administration of PGF extract (500 mg kg−1) reduced cardiac TG content, accompanied by a decrease in plasma levels of TG and total cholesterol in Zucker diabetic fatty (ZDF) rats, indicating improvement by PGF extract of abnormal cardiac TG accumulation and hyperlipidemia in this diabetic model. Treatment of ZDF rats with PGF extract lowered plasma FA levels. Furthermore, the treatment suppressed cardiac overexpression of mRNAs encoding for FA transport protein, peroxisome proliferator‐activated receptor (PPAR)‐α, carnitine palmitoyltransferase‐1, acyl‐CoA oxidase and 5′‐AMP‐activated protein kinase α2, and restored downregulated cardiac acetyl‐CoA carboxylase mRNA expression in ZDF rats, whereas it showed little effect in Zucker lean rats. The results suggest that PGF extract inhibits increased cardiac FA uptake and oxidation in the diabetic condition. PGF extract and its component oleanolic acid enhanced PPAR‐α luciferase reporter gene activity in human embryonic kidney 293 cells, and this effect was completely suppressed by a selective PPAR‐α antagonist MK‐886, consistent with the presence of PPAR‐α activator activity in the extract and this component. Our findings suggest that PGF extract improves abnormal cardiac lipid metabolism in ZDF rats by activating PPAR‐α and thereby lowering circulating lipid and inhibiting its cardiac uptake. British Journal of Pharmacology (2005) 145, 767–774. doi:10.1038/sj.bjp.0706245


  • Punica granatum flower extract, a potent α-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats

    by Yuhao Li, Suping Wen, Bhavani Prasad Kota, Gang Peng, George Qian Li, Johji Yamahara, Basil D. Roufogalis